Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Shares Outstanding: 2019-2025

Historic Shares Outstanding for Fulcrum Therapeutics (FULC) over the last 7 years, with Sep 2025 value amounting to $54.1 million.

  • Fulcrum Therapeutics' Shares Outstanding rose 0.31% to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year increase of 0.31%. This contributed to the annual value of $54.0 million for FY2024, which is 12.84% down from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Shares Outstanding of $54.1 million as of Q3 2025, which was up 0.03% from $54.1 million recorded in Q2 2025.
  • Over the past 5 years, Fulcrum Therapeutics' Shares Outstanding peaked at $62.3 million during Q2 2024, and registered a low of $32.6 million during Q1 2021.
  • For the 3-year period, Fulcrum Therapeutics' Shares Outstanding averaged around $58.3 million, with its median value being $61.8 million (2023).
  • Its Shares Outstanding has fluctuated over the past 5 years, first spiked by 51.80% in 2023, then decreased by 13.13% in 2025.
  • Quarterly analysis of 5 years shows Fulcrum Therapeutics' Shares Outstanding stood at $40.6 million in 2021, then rose by 28.24% to $52.1 million in 2022, then increased by 18.84% to $61.9 million in 2023, then decreased by 12.84% to $54.0 million in 2024, then grew by 0.31% to $54.1 million in 2025.
  • Its Shares Outstanding stands at $54.1 million for Q3 2025, versus $54.1 million for Q2 2025 and $54.0 million for Q1 2025.